![Peter J. Azzarello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter J. Azzarello
No más puestos en curso
Historial de carrera de Peter J. Azzarello
Antiguos cargos conocidos de Peter J. Azzarello.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Aviragen Therapeutics, Inc.
![]() Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Comptroller/Controller/Auditor | 28/11/2013 | 11/07/2016 |
Corporate Officer/Principal | 31/03/2013 | 28/11/2013 | |
Secretario Corporativo | 31/03/2013 | 11/07/2016 | |
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Director Financiero/CFO | 01/11/2004 | 30/09/2012 |
NetBank, Inc.
![]() NetBank, Inc. Major BanksFinance NetBank, Inc. provides on-line retail banking and mortgage lending services. It operates in two segments: Retail banking and Mortgage lending. Retail banking provides consumer banking products like checking, money market and certificates of deposit, as well as, online bill payment and presentment, eStatements, wireless account access, account consolidation and securities brokerage services. Mortgage lending provides mortgage loans and related services. The company is headquartered in Alpharetta, GA. | Corporate Officer/Principal | 01/01/2001 | 01/01/2003 |
Anaconda Pharma SASU
![]() Anaconda Pharma SASU BiotechnologyHealth Technology Anaconda Pharma SAS provides biotechnology services. It offers biotechnology services and develops treatments against infections by human papillomavirus. The company was founded in 2003 and is headquartered in Villejuif, France. | Director Ejecutivo | - | - |
Formación de Peter J. Azzarello.
Florida Atlantic University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Francia | 2 |
Operativa
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Comptroller/Controller/Auditor | 1 |
Sectorial
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
NetBank, Inc.
![]() NetBank, Inc. Major BanksFinance NetBank, Inc. provides on-line retail banking and mortgage lending services. It operates in two segments: Retail banking and Mortgage lending. Retail banking provides consumer banking products like checking, money market and certificates of deposit, as well as, online bill payment and presentment, eStatements, wireless account access, account consolidation and securities brokerage services. Mortgage lending provides mortgage loans and related services. The company is headquartered in Alpharetta, GA. | Finance |
Aviragen Therapeutics, Inc.
![]() Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
Anaconda Pharma SASU
![]() Anaconda Pharma SASU BiotechnologyHealth Technology Anaconda Pharma SAS provides biotechnology services. It offers biotechnology services and develops treatments against infections by human papillomavirus. The company was founded in 2003 and is headquartered in Villejuif, France. | Health Technology |
- Bolsa de valores
- Insiders
- Peter J. Azzarello
- Experiencia